Abstract
Most attempts at preventing infection in neutropenic hosts have involved isolation of the patient from potential disease-causing microbes and the use of prophylatic antibiotics. Laminar airflow units were an expensive approach and the principal benefit may well have come from simultaneously administered regimens that suppressed the gut flora. The relationship between colonization of the gut by organisms that can subsequently cause systemic disease and gram-negative bacteremia has been supported by many observations, but the role of the normal anaerobic gastrointestinal flora in limiting overgrowth by potentially virulent gram-negative bacilli remains controversial. Cotrimoxazole has been a popular agent for prophylaxis but has serious deficiencies including lack of activity againstPseudomonas aeruginosa. Emergence of bacterial resistance to cotrimoxazole is an increasing problem. At present, the new fluoroquinolones offer promise as active agents against most gram-negative and some gram-positive pathogens but these agents lack anti-pneumocystis activity. It is widely perceived that improvements in clinical study design are needed in order to critically evaluate new developments in the field of antibiotic prophylaxis.
Similar content being viewed by others
References
Young, L. S. Management of infections in leukemia and lymphona. In: Rubin, R. H., Young, L. S. (ed.): The clinical approach to infection in the compromised host. Plenum Press, New York, 1981, p. 461–506.
Young, L. S. Antimicrobial prophylaxis against infection in neutropenic patients. Journal of Infectious Diseases 1983, 147: 611–614.
Young, L. S. The new fluorinated quinolones for infection prevention in acute leukemia. Annals of Internal Medicine 1987, 106: 144–146.
Young, L. S. Role of granulocyte transfusions in treating and preventing infection. Cancer Treatment Report 1983, 67: 109–111.
Young, L. S. Immunoprophylaxis and serotherapy of bacterial infections. American Journal of Medicine 1984, 76: 664–671.
Levine, A. S., Siegel, S. E., Schreiber, A. D., Hauser, J., Preisler, H., Goldstein, I. M., Seidler, F., Simon, R., Perry, S., Bennett, J. E., Henderson, E. S. Protected environments and prophylactic antibiotics: a prospective controlled study of their utility in the therapy of acute leukemia. New England Journal of Medicine 1973, 288: 477–493.
Buckner, C. D., Clift, R. A., Thomas, E. D., Hersman, J., Sanders, J. E., Stewart, P. S., Wade, J. C., Murphy, M., Counts, G., Meyers, J. D. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures. Infection 1983, 11: 243–250.
Schimpff, S. C., Greene, W. H., Young, V. M., Fortner, C. L., Jepsen, L., Cusack, N., Block, J. B., Wiernik, P. H. Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Annals of Internal Medicine 1975, 82: 351–358.
Young, L. S. Nosocomial infections in the immunocompromised adult. American Journal of Medicine 1981, 70: 398–402.
Gaya, H., Adnit, P. I., Turner, P. Changes in gut flora after cephelexin treatment. British Medical Journal 1970, 3: 624–625.
van der Waaij, D., Berghuis, J. M., Lekkerkerk, J. E. C. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. Journal of Hygiene 1972, 70: 605–610.
Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., Verhoef, J. Prevention of infection with trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia. Annals of Internal Medicine 1981, 95: 555–559.
Young, L. S. Trimethoprim-sulfamethoxazole and bacterial infections during leukemia therapy. Annals of Internal Medicine 1981, 95: 508–509.
Wells, C. L., Podzorski, R. P., Peterson, P. K., Ramsay, N. K., Simmons, R. L., Rhame, F. S. Incidence of trimethoprim-sulfamethoxazole resistantEnterobacteriaceae among transplant recipients. Journal of Infectious Diseases 1984, 150: 699–706.
Karp, J. E., Merz, W. G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B. J., Bartlett, J. G., Saral, R., Burke, P. J. Oral norfloxacin for prevention of gramnegative bacterial infections in patients with acute leukemia and granulocytopenia. Annals of Internal Medicine 1987, 106: 1–7.
Dekker, A. W., Rozenberg-Arska, M., Verhoef, J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine 1987, 106: 7–12.
Pizzo, P. A., Robichand, K. J., Edwards, B., Schumaker, C., Kramer, B. S., Johnson, A. Oral antibiotic prophylaxis in cancer patients: a double blind, randomized placebo controlled trial. Journal of Pediatrics 1983, 102: 125–133.
Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal flora of patients with acute non-lymphocytic leukemia: a double-blind, placebo-controlled study. Journal of Infectious Diseases 1983, 147: 615–623.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, L.S. Antimicrobial prophylaxis in the neutropenic host: Lessons of the past and perspectives for the future. Eur. J. Clin. Microbiol. Infect. Dis. 7, 93–97 (1988). https://doi.org/10.1007/BF01962191
Issue Date:
DOI: https://doi.org/10.1007/BF01962191